Paid Clinical Trials for Cervical Cancer

Showing 21 – 36 of 36 results

Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

by CTG

in Cervical Cancer

Other

California

Deadline:

08/01/2027

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

by CTG

in Cervical Cancer, Human Papilloma Virus (HPV)

Other

Florida

Deadline:

12/31/2026

A Study of PHN-010 in Patients With Advanced Solid Tumors

by CTG

in Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Lung Cancer, Colon Cancer

Other

Florida

Deadline:

07/01/2027

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

by CTG

in Cervical Cancer

Other

Texas

Deadline:

12/01/2028

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

by CTG

in Cervical Cancer, Anal Cancer, Oropharyngeal Cancer, HPV Cancers, Vulvar, Vaginal, Penile, Rectal Cancer

Other

Maryland

Deadline:

07/01/2026

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

by CTG

in Cervical Cancer, Metastatic Cancer

Other

Texas

Deadline:

06/30/2026

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

by CTG

in Cervical Cancer

Other

Alabama

Deadline:

06/30/2026

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

by CTG

in Cervical Cancer, Endometrial Cancer, Uterine Cancer

Other

New Jersey

Deadline:

11/01/2026

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

by CTG

in Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Uterine Cancer, Ovarian Carcinoma

Other

Massachusetts

Deadline:

06/30/2029

Pembrolizumab and Olaparib in Cervical Cancer Patients

by CTG

in Cervical Cancer, Cervical Carcinoma

Other

Florida

Deadline:

11/01/2031

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

by CTG

in Cervical Cancer, Smoking Cessation, High Grade Cervical Dysplasia

Other

Florida

Deadline:

08/01/2026

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

by CTG

in Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Fallopian Tube Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2)

Other

Illinois

Deadline:

12/01/2040

Reducing Urban Cervical Cancer Disparities

by CTG

in Cervical Cancer, Papilloma Viral Infection

Other

New Jersey

Deadline:

12/01/2027

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

by CTG

in Cervical Cancer, Colorectal Cancer, Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

Other

California

Deadline:

08/31/2026

A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer

by CTG

in Cervical Cancer

Other

Connecticut

Deadline:

06/01/2028

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

by CTG

in Cervical Cancer, Solid Tumor, Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer

Other

New Mexico

Deadline:

12/01/2029

Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

A Study of PHN-010 in Patients With Advanced Solid Tumors

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Pembrolizumab and Olaparib in Cervical Cancer Patients

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Reducing Urban Cervical Cancer Disparities

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Cervical Cancer

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps